Similar articles

• Inhibition of glucagon secretion by diphenylhydantoin in a patient with glucagonoma.

  Machina T, Marcus R, Levin SR. Machina T, et al. West J Med. 1980 Apr;132(4):357-60. West J Med. 1980. PMID: 6992459 Free PMC article. No abstract available.
• [Regulation of endocrine secretion in a case of polyadenomatosis].

  Heynen GO, Luyckx A, Franchimont P, Van Cauwenberge H. Heynen GO, et al. Actual Endocrinol (Paris). 1973;13(0):275-87. Actual Endocrinol (Paris). 1973. PMID: 4152415 French. No abstract available.
• [Glucagonoma].

  Shima K. Shima K. Horumon To Rinsho. 1971 Apr;19(4):321-5. Horumon To Rinsho. 1971. PMID: 4939134 Review. Japanese. No abstract available.
• [Glucagonoma syndrome--a manifestation of neoplastic process].

  Clszewska Z, Tyburska-Trebińska A. Clszewska Z, et al. Przegl Dermatol. 1980 Sep-Oct;67(5):647-52. Przegl Dermatol. 1980. PMID: 7005973 Polish. No abstract available.
• [Pancreatic glucagon (IRG), enteroglucagon (EG)].

  Kawabe K, Ito T. Kawabe K, et al. Nihon Rinsho. 2005 Aug;63 Suppl 8:493-5. Nihon Rinsho. 2005. PMID: 16149559 Review. Japanese. No abstract available.